» Articles » PMID: 2701916

Postocclusive Reactive Hyperaemia of Cutaneous Blood Flow in Premature Newborn Infants

Overview
Specialty Pediatrics
Date 1989 Jan 1
PMID 2701916
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive hyperaemia, which occurs after a period of arterial occlusion is the result of an autoregulatory mechanism, involving local factors and autonomic nerve system control. To determine this autoregulatory mechanism in cutaneous blood flow in premature newborns measured the cutaneous reactive hyperaemia response after a 1 min occlusion, using a diode laser Doppler flowmeter applied to the skin. Twenty-four infants with a gestational age ranging from 25 to 37 weeks and a postnatal age of 0.3 to 72 days were studied. The reactive hyperaemia response is described by the parameters maximal cutaneous blood flow (Vmax), the time to reach maximal flow (tmax), the time taken for blood flow to return to baseline following Vmax (t(end)) and the % increase in cutaneous blood flow above preocclusional level (overshoot). A cutaneous reactive hyperaemia response could be elicited in all infants. Following occlusion the Vmax was 2,640 +/- 1,050 mV (mean +/- SD), the tmax was 7.6 +/- 3.9 sec (mean +/- SD), the t(end) was 35.6 +/- 14.6 sec (mean +/- SD) and the overshoot was 74.6 +/- 34% (mean +/- SD). A negative correlation was found between hematocrit and tmax (r = -0.62, p less than 0.01). No influence of postconceptional age, postnatal age, skin and rectal temperature, incubator temperature, weight, and transcutaneous oxygen tension on the reactive hyperaemia parameters could be found. We conclude that reactive hyperaemia of cutaneous blood flow can be elicited in premature newborn infants irrespective of postconceptional age, and that the hematocrit is inversely related to the time to reach maximal flow after occlusion.

Citing Articles

Baroreflex resetting but no vascular tolerance in response to transdermal glyceryl trinitrate in conscious rabbits.

Serone A, Angus J, Wright C Br J Pharmacol. 1996; 118(1):93-104.

PMID: 8733581 PMC: 1909489. DOI: 10.1111/j.1476-5381.1996.tb15371.x.